Abstract:Heterogeneity of neurodegenerative diseases, including Alzheimer’s disease (AD), has hampered precision diagnosis and prognosis. Machine learning methods are able to dissect neuroanatomical heterogeneity and enable identification of disease subtypes via their imaging signatures. We apply a novel semi‐supervised deep‐learning clustering method to derive dimensions of neurodegeneration, and investigate longitudinal paths in this dimensional system. Analyses used structural MRIs (from the Alzheimer’s Disease Neuroimaging Initiative and the Baltimore Longitudinal Study of Aging; total 2,832 participants; 8,146 scans) including controls and patients with Mild Cognitive Impairment (MCI) and AD. Smile‐GAN identified 4 neurodegenerative patterns/axes (Figure 1): P1, normal anatomy; P2, mild/diffuse atrophy; P3, focal medial temporal atrophy; P4, advanced neurodegeneration. Further application to longitudinal data revealed two distinct progression pathways: P1→P2→P4 and P1→P3→P4. Clinically, P2 participants showed worse performance in executive function than P3 participants (median ADNI‐EF= ‐0.29 vs. ‐0.1, with p=0.038) but had better memory (ADNI‐MEM= ‐0.13 vs. ‐0.39, with p=0.003) (Figure 2). Progression to P4 occurred more rapidly from P3 than P2, with median survival time to progression of 4.5 years and 3.2 years for P2 and P3 MCI/Dementia participants, respectively. Baseline expression of these patterns predicted the pathway and rate of future neurodegeneration, with high accuracy for determining whether P1 participants would progress and whether they would progress to P2 or P3 (Cox‐proportional‐hazard model average concordance index (CI) on the validation set of 0.8±0.02). Pattern expression offered better performance (CI=0.72±0.02) in predicting clinical conversion from MCI to Dementia compared to amyloid/tau (CI=0.69±0.02), with all three together showing modest improvement over pattern performance (CI=0.76±0.02). A composite risk score comprised of pattern probabilities, Abeta, pTau, presence of APOE E4, and ADAS‐cog score was able to predict survival time with an average concordance index, 0.78±0.02 on randomly split validation sets. (Figure 3). Four reproducible volumetric patterns, and 2 major longitudinal pathways were revealed using deep learning, which can be determined on an individual patient basis and has implications for rate of future decline. These pattern‐based biomarkers can enrich the N‐dimension of the A/T/N framework which may inform on clinical trial enrollment and monitoring outcomes in a more personalized manner.

Prediction of Progression to Alzheimer's disease with Deep InfoMax

Early Diagnosis of Alzheimer's Disease Using Deep Learning

DeepAD: A Robust Deep Learning Model of Alzheimer's Disease Progression for Real-World Clinical Applications

A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal MRI

Prediction of Alzhimers Disease from 4 Class of MRI Images Using Inception V3 Model in Deep Learning

Prediction of Alzheimer's Progression based on Multimodal Deep-Learning-based Fusion and Visual Explainability of Time-Series Data

Predicting Cognitive Declines Using Longitudinally Enriched Representations For Imaging Biomarkers

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data

Deep Feature Selection and Causal Analysis of Alzheimer's Disease

Alzheimer’s disease detection from magnetic resonance imaging: a deep learning perspective

Clinical Decision Support for Alzheimer's Disease Based on Deep Learning and Brain Network

Dominating Alzheimer's disease diagnosis with deep learning on sMRI and DTI-MD

Prediction and clustering of Alzheimer's disease by race and sex: a multi-head deep-learning approach to analyze irregular and heterogeneous data

Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI

Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects

Disentangling brain heterogeneity via semi‐supervised deep‐learning and MRI: Application to dimensional representations of Alzheimer’s disease

Predicting Conversion of Mild Cognitive Impairments to Alzheimer's Disease and Exploring Impact of Neuroimaging

A DEEP LEARNING-BASED FRAMEWORK FOR ALZHEIMER'S DISEASE DIAGNOSIS AND PROGRESSION PREDICTION FROM MRI IMAGES

Computer Aided Alzheimer's Disease Diagnosis by an Unsupervised Deep Learning Technology.

A deep generative multimodal imaging genomics framework for Alzheimer's disease prediction

Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network